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Summary.-A comparison has been made of the effects of the 2-nitroimidazole
Ro-07-0582 on tumour growth delay after irradiation and tumour cell survival in
vitro after irradiation in vivo. This compound has previously been shown to be a
specific sensitizer of hypoxic cells. A dose of 1 mg/g body weight gave an enhance-
ment ratio of 2*2 for both growth delay and cell survival in a system where high
pressure oxygen has been shown to have no effect. However, while the hypoxic
fraction in the tumour was estimated to be less than 10% from the growth delay
curves, the survival curves gave a value in excess of50%. This discrepancy probably
reflects differences in the response ofcells left in situ or removed and assayed in vitro.
WHETHER or not a tumour will recur the effects of modifying agents such as
after radiotherapy depends on the lethal oxygen and radiation quality. However,
effect of the radiation on the individual the criticism has been made that tumour
tumour cells. However, while it is a regrowth after irradiation reflects damage
relatively straightforward procedure to to all the components of the tumour and,
measure this lethal effect on cells directly in particular, vascular damage may con-
in the laboratory, the clinician can only tribute significantly to the observed
measure survival of the patient after growth delay (Brown and Howes, 1974).
treatment and, in certain limited condi- An agent which preferentially sensitizes
tions, tumour regression and regrowth hypoxic cells to radiation should provide
(e.g. Breur, 1966). For instance, in pre- an excellent opportunity to study the
liminary trials of the effect of an hypoxic relationship between cell survival in situ
cell sensitizer on secondary human tu- and in vitro after irradiation in vivo,
mours, the endpoint beingusedis regrowth since its effect should only be to modify
of subcutaneous and lung nodules after the survival of hypoxic cells and it
irradiation in the presence or absence should have no effect on damage to
of the sensitizer (Thomlinson, personal vascularendothelium, whichispresumably
communication). Thus, there are prac- well oxygenated.
tical reasons for studying the relationship This paper is therefore concerned
between tumour growth delay and cell with a comparison of the effects of the
survival in the laboratory. 2-nitroimidazole drug Ro-07-0582 (Roche
In previous studies on tumour growth Products Ltd, Welwyn Garden City,
delay and tumour cell survival in vitro Herts.) on tumour growth delay after
after irradiation in vivo (McNally, 1973, irradiation and tumour cell survival as-
1975) it was shown, in at least one type sayed in vitro after irradiation in vivo.
of tumour, that removal of tumour cells This compound has been shown to be a
from their normal environment after specific sensitizer of hypoxic cells in
irradiation may lead to incorrect estimates vitro (Asquith et al., 1974), giving a
of in situ cellular radiosensitivity and of sensitizing enhancement ratio (the ratioTUMOUR GROWTH DELAY AND CELL SURVIVAL 611
of the x-ray dose to produce a given for each individual tumour to grow from
effect without the drug to that with the treatment size to 11 mm. Tumours were
drug) of 2f5 at a concentration of 5 mmol. standardized to a diameter of 8-5 mm at
It has also been shown to sensitize treatment by adding or subtracting a cor-
cells in vivo, a dose of rection throughout for the small difference hypoxic tumour cells . vo min size of individual tumours at irradiation. 1 mg/g body weight giving enhancement For each radiation dose group a mean time
ratios from 1P7 to 2-2 for various endpoints to grow from 8-5 to 11 mm and its 95%
measured using a number of murine confidence limits could then be calculated
tumours (Fowler and Adams, 1975). and plotted as a function of this dose.
For cell survival studies tumours were
MATERIALS AND METHODS excised, either immediately or at various times after irradiation, and single cell The tumour used in this study was a suspensions prepared as previously described
fast growing anaplastic round-celled sarcoma (McNally, 1972). An aliquot of the unirra-
(Sarcoma F), growing in CBA mice and diated cell suspension was then exposed
previously described by Hewitt (1966). to a dose of 8 krad of 60Co gamma rays
Small pieces ofthe tumour were transplanted and 5 x 105 of these " feeder " cells were
by trochar subcutaneously on the ventral mixed with the test cells in 20 ml of Eagle's
wall of the thorax into 2-3 month old male Minimum Essential Medium plus 15% foetal
mice. Tumours were irradiated when they calf serum and antibiotics plus 0 25% Difco
had reached a mean diameter of 8-9 mm. " Noble " agar. 4 ml of this suspension
At this size the volume doubling time was was pipetted into a 50 mm plastic Petri
about 24 h. The source of radiation was a dish containing a 3 ml "base" of 0-9%
Pantak x-ray set operated at 240 kV and agar in medium so that the appropriate
15 mA (h.v.1 1-3 mm Cu, dose rate 240 number of test cells were mixed with 105
rad/min). Mice were anaesthetized with " feeder " cells. Four replicate plates were
pentobarbitone sodium before irradiation. used for each tumour cell suspension. The
Mice which did not receive the sensitizing cells were then incubated for 15-20 days
drug were given 60 mg/kg ofthe anaesthetic; at 370C in a humidified atmosphere of
those receiving the sensitizer had approxi- 5% 002 in air. Macroscopic colonies were
mately three-quarters of this dose since the counted and survival curves constructed.
sensitizer itself had a mild anaesthetic
effect. In some experiments the tumours
were irradiated with their blood supply RESULTS
occluded by a semicircular aluminium clamp The times for tumours to grow from
applied between the tumour and the chest treatment size (8.5 mm) to 11 mm
wall 15 min before the start of irradiation, diameter after exposure to various doses
to render all the tumour cells hypoxic of x-rays (Denekamp and Harris, 1975). Mice treated are plotte. as a fun ofter with Ro-07-0582 were given either 1 mg/g x-ray dose inFg. 1. The tumours were
body weight or 0-2 mg/g of the drug (dis- unclamped and animals were breathing
solved in saline) by intraperitoneal injection air. The animals treated with Ro-07-0582
30 min before the start of irradiation. had received 1 mg/g 30 min before
In order to measure the gross response starting the irradiation. Each point rep-
of tumours to radiation, each tumour was resents data from 6-8 animals, except
measured 3-5 times per week over 3 mutually for that for 2000 rad plus Ro-07-0582 for
perpendicular diameters until it reached a which there were only 4 mice. The
mean diameter of 13-5 mm, when the mouse error bars in Fig. 1 represent the 95% was killed. The geometric mean diameter confidence limits.
was calculated for each individual tumour
for each day. Growth curves were then her 2 largest doses of radiation de-
constructed by plotting the mean diameter livered to tumours that had received
for a group of animals receiving the same the sensitizer (2500 and 3000 rad) pro-
treatment against time. Dose-effect curves duced some apparent local cures, in that
were constructed by measuring the time 2 of the 7 animals whose tumours had612 N. J. MCNALLY
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FIG. 1.-Dose effect curves for Sarcoma F. The effect is the time to grow from the diameter when
irradiated (8-5 mm) to 11 mm. The vertical lines indicate the 95% confidence limits. The
arrows indicate that the points represent minimum estimates of the time to grow to 11 mm.
O Irradiations in air, 0 irradiations in air 30 min after intraperitoneal injection of 1 mg/g
Ro-07-0582. The dashed lines represent an extension of the hypoxic component to doses less
than 2000 rad and the effect of sensitization of this component by factors 1 4, 2*0 and 2*2 on the
overall dose-ffect curve.
received 2500 rad and 5 of the 7 that mum estimates of the delay induced by
had received 3000 rad had to be killed these 2 doses of radiation. The curve
due to lung metastases at times when for tumours irradiated in the absence of
there was no evidence of regrowth of the the sensitizer had the biphasic shape
primaries. The 2 points in Fig. 1 indi- characteristic of a mixed population of
cated by arrows therefore represent mini- oxic and hypoxic cells (Thomlinson andTUMOUR GROWTH DELAY AND CELL SURVIVAL 613
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Fic. 2.-Growth curves for tumours irradiated with 1000 rad alone or with 1000 rad plus 1 mg/g
Ro-07-0582 immediately after irradiation. The vertical lines indicate 95% confidence limits.
Craddock, 1967). The effect of the sen- a dose of 2000 rad, ifthe drug was present
sitizer was to displace the dose at which before irradiation, the delay in regrowth
this biphasic shape became apparent from was 3 times greater than if it was absent
about 2000 rad to probably well over but that adding the drug after irradiation
2500 rad (Fig. 1). only increased the delay by 10-20%.
Even at low doses of radiation some The enhancement ratio for growth
sensitization was apparently produced by delay measured from Fig. 1 ranges from
Ro-07-0582. However, this was because 1725 for a growth delay of 9 days to
there was a slight effect of the drug if 2-0 for a delay of 15 days. This de-
administered after irradiation. Figure 2 pendence on the level of damage is
shows growth curves for tumours receiving because of the biphasic nature of the
1000 rad alone or given 1 mg/g of the dose-effect curve for irradiations in the
drug immediately after irradiation. The absence of the sensitizer, reflecting the
effect of the drug was to increase the response ofa mixedpopulation ofoxic and
time taken to grow to 11 mm from 5 hypoxic cells.
to 7*3 days. It is not possible to allow Figure 3 shows survival values for
for this post-irradiation effect in calculat- the cells of this tumour irradiated in
ing the radiosensitizing effect of Ro-07- vivo in the absence of the sensitizer and
0582 since it has been measured only assayed in vitro. The animals were
after one dose of radiation. However, breathing air and the tumours were
it is not likely to contribute significantly either clamped or unclamped. The line
to the measured enhancement ratio since was drawn by eye through the points.
Denekamp and Harris (1975), using a Clamping the tumour did not significantly
different transplanted tumour in CBA increase the resistance of the cells to
mice (carcinoma NT), showed that for radiation, implying a large hypoxic frac-614 N. J. MCNALLY
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FIG. 3.-Survival values for the cells ofSarcoma F irradiated in vivo and assayed in vitro. 0 Animals
breathing air, x animals breathing air and the tumours clamped 15 min before irradiation.
Typical standard errors are shown on some of the points. The line was drawn by eye through all
the points.
tion. The survival curves for cells from The enhancement ratio for 1 mglg
unclamped tumours irradiated in the Ro-07-0582 was 2-2 and for 0-2 mg/g it
presence of either 1.0 mg/g or 0-2 mg/g was 1-3. This independence of the en-
of Ro-07-0582 are shown in Fig. 4. The hancement ratio on the x-ray dose con-
survival curve for cells from unclamped trasts with the lack of a significant
tumours irradiated in the absence of effect of Ro-07-0582 on growth delay
the sensitizer, redrawn from Fig. 3, has for x-ray doses less than about 1500 rad
been included for comparison. The effect (Fig. 1).
of the sensitizer was essentially dose
modifying because of the large hypoxic
fraction. The Do for irradiations in the DISCUSSION
absence of the drug was 350 rad, that Figures 1 and 4 clearly demonstrate
for irradiations in the presence of 1 mg/g that Ro-07-0582 is an effective sensitizer
was 160 rad and for 0-2 mg/g it was of naturally occurring hypoxic cells in
270 rad. The x-ray dose enhancement tumours. If it can be assumed that the
ratio for each drug concentration can delay in regrowth for doses larger than
be taken as the ratio of the Do in the about 2000 rad is a reflection of the
absence ofthe drug to that in its presence response of hypoxic cells (Fig. 1), then
because the drug was dose modifying. it is possible to estimate an enhancementTUMOUR GROWTH DELAY AND CELL SURVIVAL 615
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FIG. 4.-Survival curves for the cells of Sarcoma F irradiated in air breathing animals in the
presence of no drug (0), 0*2 mg/g Ro-07-0582 (A) or 1 mg/g Ro-07-0582 (0).
ratio for hypoxic cells left in situ. This a value of about 50% (Hewitt and
was done by constructing hypothetical Wilson, 1961), so that any sensitization
growth curves assuming uniform sen- by HPO would have been easily detected.
sitization of the hypoxic cells by x-ray Hewitt expressed his results as the ratio
dose enhancement ratios of 1-4, 2-0 and of the surviving fraction of cells after
2-2. These hypothetical curves are repre- irradiation ofthe tumourin micebreathing
sented by the dashed lines in Fig. 1. The air to that after irradiation breathing
enhancement ratio of 1-4 does not fit oxygen, at a given dose of x-rays. Signi-
the data. The value of 2-0 probably ficant sensitization should give a ratio
represents a minimum estimate of the of cell survival greater than 1 by one or
enhancement ratio, while the value of more orders of magnitude, particularly
2-2 is in good agreement with the data at doses greater than 1000 rad. In the
and also agrees with that deduced from Table Hewitt's results are compared with
the survival curves (Fig. 4). the present ones using Ro-07-0582. The
Hewitt (1966) studied the sensitizing smallest dose he used was 2040 rad but
effect of high pressure oxygen (HPO) for all the x-ray doses used he found no
on cell survival in the present tumour real effect of breathing oxygen. In the
system and found no significant sensitiza- present experiments, however, a dose of
tion using his dilution assay. He used 1000 rad killed 25 times more cells in
this tumour because his previous estimate the presence of 1 mg/g Ro-07-0582 than
of the hypoxic fraction had indicated in its absence and a dose of 2040 rad616 N. J. MCNALLY
TABLE.-The Effects of Ro-07-0582 or cells are irradiated in vivo, removed and
High Pressure Oxygen on Survival of subsequently injected into other mice.
the Cells of Sarcoma F Assayed either Begg (personal communication) deduced
in vitro (Present Results) or in vivo that there was a relatively low hypoxic
(Hewitt, 1966) after Irradiation in vivo fraction using an assay which, like
Surviving fraction Surviving fraction growth delay, does not involve removal
(air)* (air)* of cells from their normal environment.
He measured the amount of radioactivity
Surviving fraction Surviving fraction
Dose Ro-07-0582 (HPO) i tumours as a function of time after
(rad) (present results) (Hewitt, 1966) a single intraperitoneal injection of 1251_
1000 25 - iododeoxyuridine to the mice. This tech-
2260 >100 0 73 nique can be used to assess quantitatively
2580 2-8 the death of cells in vivo following irradia-
3280 1 7 tion (Hofer, 1970; Begg and Fowler,
* Ro-07-0582 I mg/g 1974). Begg found a large difference in
HPO 45 p.s.i. the doses of x-rays needed to produce the
same loss of radioactivity when tumours
were irradiated either clamped or
would, by extrapolation of the curves unclamped, indicating that in the
of Fig. 4, increase this ratio to over 100. unclamped situation the proportion of
The absence of an effect of oxygen in hypoxic cells was small.
Hewitt's experiment may have been Thus, the 2 techniques in which cells
because of its rapid metabolism, or be- are left in situ (growth delay and loss
cause of a vasoconstrictive effect of the of 1251 activity) gave lower estimates of
high pressure (e.g. Lambertsen, 1966). the hypoxic fraction than those in which
The 2 methods of assay used in the the cells are removed from the mice
present study gave quite different esti- after irradiation (cell survival in Petri
mates of the hypoxic fraction of cells in dishes and in recipient mice). A possible
the tumour even though they gave the explanation for this discrepancy is that
same estimate of the enhancement ratio " doomed " hypoxic cells which would
for Ro-07-0582. As in Hewitt's results, die if left in situ, even though they have
the hypoxic fraction was apparently well survived the radiation, are " rescued "
over 50% when it was determined by from death due to hypoxia when the
the assay of cells in vitro since (a) there tumour is excised and a single cell suspen-
was little effect of clamping the tumour tion obtained (McNally, 1973).
on cell survival (Fig. 3) and (b) Ro-07-0582 In order to test this possibility, un-
was essentially dose modifying (Fig. 4). clamped tumours were exposed to single
In contrast, the growth delay curves doses of 2000 rad (animals breathing
(Fig. 1) suggest that the " effective " in air), excised at various times after irradia-
situ hypoxic fraction was probably well tion and the cells assayed for their colony
below 10% because (a) the resistant forming ability. If hypoxic cells that
portion did not affect the growth delay had survived the irradiation died due to
curves at doses less than about 2000 rad hypoxia or other nutrient deficiency,
and (b) there was little effect ofRo-07-0582 there should be a fall in survival as the
below this dose. interval between irradiation and excision
Two other estimates of the hypoxic increased. Figure 5 shows that this was
fraction in sarcoma F have been made. not the case; the surviving fraction of
Hewitt and Wilson (1961), as mentioned cells increased with time up to 8 h by
above, deduced that the hypoxic fraction a factor of 5-10 and showed no consistent
was about 50% when they assayed the change thereafter. The scatter in the
cells by their dilution method in which data does not exclude a small fall inTUMOUR GROWTH DELAY AND CELL SURVIVAL 617
10-1 - posed another explanation for the dis-
F crepancy in the estimates of the hypoxic
I* fraction. They suggested that vascular
I* damage can contribute to the observed
I * *o . . growth delay, causing extra delay in o * regrowth of tumours in air-breathing
0~~~~~ t animals. The effect of this would be to o * displace the transition region from an
I . oxic to a hypoxic response to larger doses
.c 1o2H. of radiation than if such damage were
> absent, thus decreasing the estimate of
> the hypoxic fraction. Reasons why such
an explanation may not apply have been
discussed previously (McNally, 1974) and
will not be repeated here. Nevertheless,
we must consider the consequences of
applying this explanation to the present
10-3 I I I I I I results. If the effective hypoxic fraction in situ were in excess of 50% as the
0 12 24 survival curves imply (Fig. 3), this would
Time after irradiation (h) mean that even at the lowest dose of
FIG. 5.-Theeffect of timebetweenirradiation radiation used in the absence of the
in vivo and excision onthesurvival in vitro sensitizer (1000 rad) the growth delay
of the cells ofSarcoma Fexposedto a single should reflect primarily the response of dose of 2000 rad.
hypoxic cells plus this vascular damage.
One would not then expect to see a
survival, within the first hour or two, but biphasic response such as in Fig. 1 unless
this is certainly not sufficient to account a portion of the vascular endothelium
for the difference in the estimates of the were hypoxic. This seems unlikely. Fur-
hypoxic fraction. The observed increase ther, there should be an effect of Ro-07-
in surviving fraction with time (Fig. 5) 0582 at doses less than 2000 rad unless
is probably due to recovery from poten- the effect of the vascular damage far
tially lethal damage (Hahn and Little, outweighed that of cell killing in causing
1972), although if cells which had been growth delay. This, too, seems unlikely.
killed by the radiation become pycnotic A more likely explanation for the
and lysed soon after irradiation so that discrepancy in the estimates of the
they were not counted in the haemacyto- hypoxic fraction is that assays which
meter, this could lead to an apparent involve removal of cells from their normal
increase in survival. This possibility can- environment after irradiation do not
not be excluded although the yield of accurately reflect the course of events
cells by the trypsinization procedure and in the undisturbed tumour (McNally,
the proportion of intact cells in the 1973). It is known that the degree of
haemacytometer didnotnoticeably change intercellular contact can affect a cell's
with time between irradiation and ex- ability to absorb radiation damage as
cision ofthe tumour. It can be concluded sub-lethal (Durand and Sutherland, 1972).
that either there was no progressive In tumours, it may differentially affect
decrease in cell survival due to hypoxia, the radioresistance of hypoxic and aerobic
or the recovery from potentially lethal cells. In particular, hypoxic cells may
damage more than compensated for such be more radiosensitive when left in situ
hypoxic death. than when plated in vitro. Alternatively,
Brown and Howes (1974) have pro- the present results are consistent with618 N. J. MCNALLY
more radioresistance of cells in contact
(i.e. in situ) than when separated, if
the cells are aerobic but not if they are
hypoxic.
In summary, the results presented in
this paper demonstrate that the 2-nitro-
imidazole Ro-07-0582 is an effective sen-
sitizer of naturally occurring hypoxic
tumour cells in a system where high
pressure oxygen has been shown to have
no effect. The sensitizing enhancement
ratio deduced from the growth curves in
which cells are left in situ (Fig. 1) is in
agreement with that measured by the in
vitro assay of cell survival (Fig. 4).
However, the 2 methods of assay give
quite different estimates of the hypoxic
fraction. This discrepancy is probably
a reflection of differences in the expression
of radiation damage by cells left in situ
and those assayed in vitro.
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